Sugi Predict

Sugi Predict / Targets / UBXN1

UBXN1

UBX domain-containing protein 1 · Q04323 · UBXN1 on Sugi Atlas →

0 patent compounds predicted against UBXN1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to UBXN1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer PHASE1/PHASE2COMPLETED
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer PHASE1/PHASE2COMPLETED
Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers PHASE2NOT_YET_RECRUITING
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer PHASE1/PHASE2COMPLETED
A Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis PHASE2COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer PHASE1COMPLETED
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome nanCOMPLETED
A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS nanRECRUITING
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma nanCOMPLETED
A Natural History Study of Angelman Syndrome nanRECRUITING
Diagnostic Potential of UCHL1 in Acute Decompensated Heart Failure nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Exercise Therapy to Reduce Heart Failure Symptoms; Sorting Mechanisms of Benefit nanCOMPLETED
Whole Genome Scan of Extended Families With Familial Vocal Cord Paralysis nanCOMPLETED
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Autophagy Bladder Cancer nanUNKNOWN
New Strategies of Genetic Study of Patients With Oculocutaneous Albinism nanCOMPLETED
Identification of Genes and Pathogenesis Involved in Familial Thoracic Aortic Aneurysm nanCOMPLETED
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease nanUNKNOWN
PCD New Gene Discovery nanCOMPLETED
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors nanNOT_YET_RECRUITING
Better Delineation of DDX3X Related Phenotype and Epigenetic Signature. nanUNKNOWN
Study of a Candidate Gene Involved in Goldenhar Syndrome. nanCOMPLETED
Gene Analysis of Parkinson's Disease nanCOMPLETED
Stakeholders of Rare Diseases Informing Values In Neuroethics nanRECRUITING
Genetic Basis of Abdominal Aortic Aneurysm nanCOMPLETED
A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis nanWITHDRAWN
Relationship Between Nutritional State and Respiratory Muscle Weakness in Adult Patients With Bronchietasis nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a UBXN1 binder may also engage these)

ProteinNameSimilarity
Q499N6 — 0.997 Q499N6 →
Q32KW2 — 0.996 Q32KW2 →
Q922Y1 — 0.995 Q922Y1 →
Q6GLV4 — 0.986 Q6GLV4 →
Q6GL77 — 0.984 Q6GL77 →
Q6IP50 — 0.983 Q6IP50 →
Q99PL6 — 0.970 Q99PL6 →
Q5T0F9 — 0.968 Q5T0F9 →
Q2KIJ6 — 0.968 Q2KIJ6 →
DDRGK1 DDRGK domain-containing protein 1 0.967 landscape →
Q60596 — 0.966 Q60596 →
Q9Y6D9 — 0.966 Q9Y6D9 →
Q9BZV1 — 0.966 Q9BZV1 →
O60232 — 0.965 O60232 →
O54935 — 0.965 O54935 →
Q8BRN9 — 0.965 Q8BRN9 →
F1MX48 — 0.964 F1MX48 →
Q9CZT4 — 0.964 Q9CZT4 →
Q9BWU0 — 0.963 Q9BWU0 →
P56873 — 0.963 P56873 →
Q17QM6 — 0.963 Q17QM6 →
Q6NXA9 — 0.963 Q6NXA9 →
Q5PPF5 — 0.962 Q5PPF5 →
C5IJB0 — 0.962 C5IJB0 →
Q9H8Y5 — 0.962 Q9H8Y5 →
Q8BMI3 — 0.962 Q8BMI3 →
Q99LE1 — 0.962 Q99LE1 →
Q5FVK6 — 0.962 Q5FVK6 →
Q1JQC5 — 0.962 Q1JQC5 →
Q66H85 — 0.961 Q66H85 →